Prokidney (PROK) Asset Utilization Ratio (2024 - 2026)

Prokidney (PROK) reported Asset Utilization Ratio of 0.0 for Q1 2026, up 291.67% year-over-year from 0.0 in Q1 2025, and up 8.87% quarter-over-quarter from 0.0 in Q4 2025.

Prokidney (PROK) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Prokidney (PROK) has 3 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.0, up 291.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0 (up 291.67% YoY), and the FY2025 annual result was 0.0, up 1203.56% from the prior year.
  • Asset Utilization Ratio improved to 0.0 in Q1 2026 per PROK's latest filing, from 0.0 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.0 in Q1 2026 and troughed at 0.0 in Q4 2024.
  • A 3-year average of 0.0 and a median of 0.0 in 2025 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio surged 1466.02% in 2025, then jumped 291.67% in 2026.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.0 in 2024, then surged by 1466.02% to 0.0 in 2025, then increased by 8.87% to 0.0 in 2026.
  • Business Quant data shows PROK's Asset Utilization Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prokidney 259.01 Mn 1.55 Bn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00